Related Experiment Video
Updated: Dec 4, 2025

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Local Vibrational Therapy for Essential Tremor Reduction: A Clinical Study
Silvijus Abramavičius1, Mantas Venslauskas2, Antanas Vaitkus3
1Laboratory of Preclinical Drug Investigation Institute of Cardiology, Lithuanian University of Health Sciences 1, 44307 Kaunas, Lithuania.
A novel vibrational medical device demonstrated efficacy in reducing essential tremor (ET) symptoms for some patients. The device, a local hand-arm vibration tool, proved safe for ET treatment, with most participants reporting improved tremor and function.
Area of Science:
- Neurology
- Biomedical Engineering
- Medical Devices
Background:
- Essential Tremor (ET) is an involuntary movement disorder impacting quality of life.
- Pharmacotherapy is the current standard treatment for ET.
- Innovative interventions are needed to manage ET symptoms effectively.
Purpose of the Study:
- To evaluate the tremor reduction efficacy of an innovative medical device (IMD) in Essential Tremor patients.
- To assess the safety and functional outcomes associated with the IMD.
- To investigate the impact of local hand-arm vibration therapy on tremor severity.
Main Methods:
- A prospective, single-center, single-arm pragmatic study was conducted.
- The study involved 17 Essential Tremor patients in the main efficacy assessment.
- An extended safety study included 51 patients with Essential Tremor or Parkinsonian tremor.
Main Results:
- The device use resulted in a statistically significant reduction in tremor power spectrum (p=0.027).
- In the extended safety study, 48/51 patients reported improved tremor symptoms and 49/51 improved function.
- No serious adverse events were reported; some patients experienced lack of efficacy or increased tremor.
Conclusions:
- The vibrational medical device shows potential for reducing essential tremor in a subset of patients.
- The device is safe for use in Essential Tremor patients.
- Further research may explore personalized treatment approaches for optimal outcomes.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Skeletal Muscle Relaxants: Therapeutic Uses

